The global diabetes injection pens market is projected to grow at a CAGR of approximately 7% through 2028. Market expansion ...

The launch of an oral semaglutide pill approved for weight loss represents a new frontier for GLP-1 drugs. Katie Rosseinsky ...

WANNABE slimmers were today urged not to suddenly restart fat jabs at the same dose after pressing pause over Christmas.

In the fight against climate change, companies are navigating compounding problems: supply-chain issues, tariffs, changing ...

Wegovy for weight loss is a medical treatment that mimics a natural gut hormone to suppress hunger and support significant, ...

From injectables to pills: how the new Wegovy tablet will change the weight loss market forever - IN FOCUS: The launch of an ...

Makers of smartwatches and other wearables have spent years trying to measure blood sugar without pricking your skin. The ...

Novo Nordisk’s Wegovy weight loss pill hit U.S. pharmacies this week. Here’s how it works, who qualifies, how to take it, ...

The lowest doses of the daily pill will cost $149 a month for people paying out of pocket, offering a cheaper alternative to ...

Novo Nordisk has launched the Wegovy pill in the US, offering a 1.5 mg starter dose of semaglutide, expanding its weight-loss ...

MNT speaks with three obesity medicine experts to find out more about the FDA-aproved Wegovy pill and how it's different from the Wegovy injection.

Novo Nordisk faces GLP-1 headwinds after the FDA-approved Wegovy pill, and LLY gains share, margins erode, and the pipeline ...